Composition and biological activity of traditional and commercial kava extracts

被引:60
作者
Côté, CS [1 ]
Kor, C [1 ]
Cohen, J [1 ]
Auclair, K [1 ]
机构
[1] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada
关键词
kava; Piper methysticum; kavalactone; methysticin; kavain; yangonin; P450; CYP; inhibition; inhibit;
D O I
10.1016/j.bbrc.2004.07.093
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
For centuries the South Pacific islanders have consumed kava (Piper methysticum) as a ceremonial intoxicating beverage. More recently, caplets of kava extracts have been commercialized for their anxiolytic and antidepressant activities. Several cases of hepatotoxicity have been reported following consumption of the commercial preparation whereas no serious health effects had been documented for the traditional beverage. A detailed comparison of commercial kava extracts (prepared in acetone, ethanol or methanol) and traditional kava (aqueous) reveals significant differences in the ratio of the major kavalactones. To show that these variations could lead to differences in biological activity, the extracts were compared for their inhibition of the major drug metabolizing P450 enzymes. In all cases (CYP3A4, CYP1A2, CYP2C9, and CYP2C19), the inhibition was more pronounced for the commercial preparation. Our results suggest that the variations in health effects reported for the kava extracts may result from the different preparation protocols used. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 31 条
[1]   Coma from the health food store: Interaction between kava and alprazolam [J].
Almeida, JC ;
Grimsley, EW .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (11) :940-941
[2]   Kava hepatotoxicity: Are we any closer to the truth? [J].
Anke, J ;
Ramzan, I .
PLANTA MEDICA, 2004, 70 (03) :193-196
[3]  
[Anonymous], 2001, MED PLANTS PHYTOMEDI
[4]   Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats [J].
Baum, SS ;
Hill, R ;
Rommelspacher, H .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (07) :1105-1120
[5]   Kava-kava and anxiety: Growing knowledge about the efficacy and safety [J].
Bilia, AR ;
Gallon, S ;
Vincieri, FF .
LIFE SCIENCES, 2002, 70 (22) :2581-2597
[6]  
Cauffield J S, 1999, Lippincotts Prim Care Pract, V3, P290
[7]   Kava kava: examining new reports of toxicity [J].
Clouatre, DL .
TOXICOLOGY LETTERS, 2004, 150 (01) :85-96
[8]   Liver function test abnormalities in users of aqueous kava extracts [J].
Clough, AR ;
Bailie, RS ;
Currie, B .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2003, 41 (06) :821-829
[9]   Health effects of kava use in an eastern Arnhem Land Aboriginal community [J].
Clough, AR ;
Jacups, SP ;
Wang, Z ;
Burns, CB ;
Bailie, RS ;
Cairney, SJ ;
Collie, A ;
Guyula, T ;
McDonald, SP ;
Currie, BJ .
INTERNAL MEDICINE JOURNAL, 2003, 33 (08) :336-340
[10]  
de Montellano P.R. Ortiz., 1995, CYTOCHROME P450 STRU